CD40 and neoplasm: reported that CD40L+ CAR-Ts are also capable of increasing the immunogenicity of CD40+ tumor cells by increasing the expression level of HLA molecules, costimulatory molecules, Fas receptor, and adhesion molecules such as CD70 (149).